135 related articles for article (PubMed ID: 4007623)
1. Assessment of clinical efficacy and tolerability of terconazole 240-mg vaginal suppositories.
Litschgi M
Gynakol Rundsch; 1985; 25 Suppl 1():59-66. PubMed ID: 4007623
[No Abstract] [Full Text] [Related]
2. Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis.
Goormans E
Gynakol Rundsch; 1985; 25 Suppl 1():74-82. PubMed ID: 3891540
[No Abstract] [Full Text] [Related]
3. Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis.
Loendersloot EW
Gynakol Rundsch; 1985; 25 Suppl 1():99-104. PubMed ID: 4007627
[No Abstract] [Full Text] [Related]
4. Treatment of vaginal candidosis with three 80-mg terconazole vaginal suppositories: results of a multicentre study in France.
Nahmanovici C
Gynakol Rundsch; 1985; 25 Suppl 1():52-8. PubMed ID: 3891539
[No Abstract] [Full Text] [Related]
5. Terconazole for the treatment of vulvovaginal candidiasis.
Thomason JL; Gelbart SM; Kellett AV; Scaglione NJ; Gotwalt KT; Broekhuizen FF
J Reprod Med; 1990 Nov; 35(11):992-4. PubMed ID: 2277372
[TBL] [Abstract][Full Text] [Related]
6. Terconazole for Candida vaginitis.
Med Lett Drugs Ther; 1988 Dec; 30(782):118-9. PubMed ID: 3200220
[No Abstract] [Full Text] [Related]
7. Single-day topical treatment of vaginal candidosis: an open evaluation of terconazole 240-mg vaginal suppositories versus isoconazole tablets 600 mg.
Münnich W; Hiltl BP
Gynakol Rundsch; 1985; 25 Suppl 1():90-8. PubMed ID: 4007626
[No Abstract] [Full Text] [Related]
8. Advantages of a 6- to 7-day treatment with 40-mg vaginal suppositories of terconazole against vaginal candidosis: conclusions drawn from a phase II multicentre study in France.
Delecour M
Gynakol Rundsch; 1985; 25 Suppl 1():42-51. PubMed ID: 3891538
[No Abstract] [Full Text] [Related]
9. One-day treatment of vaginal candidosis: comparison of terconazole 240-mg suppository with clotrimazole 500-mg vaginal tablet.
Grice G; Spencer RC; Steele CE; Kinghorn GR
Gynakol Rundsch; 1985; 25 Suppl 1():83-9. PubMed ID: 3891541
[No Abstract] [Full Text] [Related]
10. Comparative open evaluation of efficacy and tolerability of terconazole 0.8% cream in a 5-day regimen versus clotrimazole 100-mg tablets in a 6-day regimen.
Wesel S; Benijts G; Ubachs JM; Dogniez B
Gynakol Rundsch; 1985; 25 Suppl 1():67-73. PubMed ID: 4007625
[No Abstract] [Full Text] [Related]
11. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Li T; Zhu Y; Fan S; Liu X; Xu H; Liang Y
Med Mycol; 2015 Jun; 53(5):455-61. PubMed ID: 25877666
[TBL] [Abstract][Full Text] [Related]
12. Summary of clinical studies with vaginal formulations of terconazole.
Martinek G
Gynakol Rundsch; 1985; 25 Suppl 1():105-13. PubMed ID: 3891536
[No Abstract] [Full Text] [Related]
13. Comparison of 0.8% and 1.6% terconazole cream in severe vulvovaginal candidiasis.
Schmitt C; Sobel J; Meriwether C
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):414-6. PubMed ID: 2381618
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of terconazole. United states experience.
Thomason JL
J Reprod Med; 1989 Aug; 34(8 Suppl):597-601. PubMed ID: 2677365
[TBL] [Abstract][Full Text] [Related]
15. Terconazole 0.8% vaginal cream (5 days) versus clotrimazole 1% (6 days): efficacy and tolerability in an open study.
Siedentopf HG
Gynakol Rundsch; 1985; 25 Suppl 1():33-41. PubMed ID: 4007622
[No Abstract] [Full Text] [Related]
16. Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison.
Corson SL; Kapikian RR; Nehring R
J Reprod Med; 1991 Aug; 36(8):561-7. PubMed ID: 1941796
[TBL] [Abstract][Full Text] [Related]
17. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
Kjaeldgaard A
Pharmatherapeutica; 1986; 4(8):525-31. PubMed ID: 3520601
[TBL] [Abstract][Full Text] [Related]
18. Terconazole--a new antifungal agent for vulvovaginal candidiasis.
Weisberg M
Clin Ther; 1989; 11(5):659-68. PubMed ID: 2680088
[TBL] [Abstract][Full Text] [Related]
19. Terconazole cream and suppositories: plasma terconazole following vaginal administration.
Kennedy BK; Friedmann N
Gynakol Rundsch; 1985; 25 Suppl 1():26-32. PubMed ID: 4007621
[No Abstract] [Full Text] [Related]
20. Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.
Doering PL; Santiago TM
DICP; 1990 Nov; 24(11):1078-83. PubMed ID: 2275233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
